Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  DaVita Inc.    DVA

DAVITA INC.

(DVA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
10/26/2020 10/27/2020 10/28/2020 10/29/2020 10/30/2020 Date
89.71(c) 89.15(c) 86.27(c) 85.77(c) 86.25(c) Last
665 183 502 042 889 371 1 099 370 1 083 913 Volume
-1.47% -0.62% -3.23% -0.58% +0.56% Change
More quotes
Financials (USD)
Sales 2020 11 579 M - -
Net income 2020 809 M - -
Net Debt 2020 7 200 M - -
P/E ratio 2020 13,0x
Yield 2020 -
Sales 2021 11 840 M - -
Net income 2021 855 M - -
Net Debt 2021 7 063 M - -
P/E ratio 2021 11,4x
Yield 2021 -
Capitalization 9 660 M 9 660 M -
EV / Sales 2020 1,46x
EV / Sales 2021 1,41x
Nbr of Employees 65 000
Free-Float 89,4%
More Financials
Company
DaVita Inc. specializes in providing dialysis services. Net sales break down by activity as follows: - supply of dialysis services (95.7%): hemodialysis and peritoneal dialysis services for patients suffering from chronic renal failure. At the end of 2019, services are insured through 2,753 dialysis centers serving nearly 206,900 patients in the United States, and through 259 dialysis centers serving nearly 28,700... 
More about the company
Notations Surperformance© of DaVita Inc.
Trading Rating : Investor Rating :
More Ratings
All news about DAVITA INC.
10/29DAVITA : Management's Discussion and Analysis of Financial Condition and Results..
AQ
10/29DAVITA INC. : Results of Operations and Financial Condition, Financial Statement..
AQ
10/29DAVITA INC. : 3rd Quarter 2020 Results
PR
10/15DAVITA INC. : Schedules 3rd Quarter 2020 Investor Conference Call
PR
10/12EXCLUSIVE : Mitsui & Co to sell all stakes in coal-fired power plants by 2030 - ..
RE
10/05DAVITA INC. : Change in Directors or Principal Officers (form 8-K)
AQ
09/17DAVITA : Announces Final Results Of Self-Tender Offer
PR
09/15DAVITA : Announces Preliminary Results of Self-Tender Offer
PR
09/08DAVITA INC. : Change in Directors or Principal Officers (form 8-K)
AQ
09/08DAVITA : Announces Shawn Guertin Will Join its Board of Directors
PR
08/27DAVITA : Opens Its Doors to Hurricane Laura Evacuees Needing Dialysis
PR
08/20DAVITA : Clinical Research Trials Underway to Study COVID-19 Impact on Dialysis ..
PR
08/17DAVITA INC. : Regulation FD Disclosure, Other Events (form 8-K)
AQ
08/17DAVITA : Commences Self-Tender Offer To Purchase For Cash Shares Of Its Common S..
PR
08/13DAVITA : Expands Initiative to Advance Nursing Education
PR
More news
News in other languages on DAVITA INC.
02/05DAVITA INC. : Veröffentlichung des Jahresergebnisses
02/05DAVITA INC. : publication des résultats annuels
2019FRESENIUS/FMC IM FOKUS : Auf Kurs - Mit Risiken und Nebenwirkungen
2019AKTIE IM FOKUS : FMC unter schwächsten Dax-Werten - Sorgen um US-Dialysegeschäft
2019US-Apothekenkette CVS will in den Heimdialyse-Markt - FMC-Aktie unter Druck
More news
Chart DAVITA INC.
Duration : Period :
DaVita Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends DAVITA INC.
Short TermMid-TermLong Term
TrendsBullishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Average target price 97,45 $
Last Close Price 86,25 $
Spread / Highest target 27,5%
Spread / Average Target 13,0%
Spread / Lowest Target -6,09%
EPS Revisions
Managers
NameTitle
Javier J. Rodriguez Chief Executive Officer & Director
Pamela M. Arway Chairman
Joel Ackerman Chief Financial Officer
Jeff Giullian Chief Medical Officer
John M. Nehra Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
DAVITA INC.14.95%9 660
CVS HEALTH CORPORATION-24.50%73 196
HCA HEALTHCARE, INC.-16.15%41 938
FRESENIUS MEDICAL CARE AG & CO. KGAA-0.58%22 379
LABORATORY CORPORATION OF AMERICA HOLDINGS18.09%19 458
QUEST DIAGNOSTICS14.37%16 572